2021 Q2 Form 10-Q Financial Statement
#000110465921108600 Filed on August 23, 2021
Income Statement
Concept | 2021 Q2 | 2020 Q2 |
---|---|---|
Revenue | $169.6M | |
YoY Change | ||
Cost Of Revenue | $126.2M | |
YoY Change | ||
Gross Profit | $43.41M | |
YoY Change | ||
Gross Profit Margin | 25.6% | |
Selling, General & Admin | $6.277M | |
YoY Change | ||
% of Gross Profit | 14.46% | |
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $89.00K | |
YoY Change | ||
% of Gross Profit | 0.21% | |
Operating Expenses | $6.277M | |
YoY Change | ||
Operating Profit | $16.33M | -$31.88K |
YoY Change | -51304.44% | |
Interest Expense | $4.476M | |
YoY Change | ||
% of Operating Profit | 27.42% | |
Other Income/Expense, Net | -$4.476M | -$8.452M |
YoY Change | -47.04% | |
Pretax Income | $11.85M | |
YoY Change | ||
Income Tax | $77.00K | |
% Of Pretax Income | 0.65% | |
Net Earnings | $11.77M | -$8.484M |
YoY Change | -238.76% | |
Net Earnings / Revenue | 6.94% | |
Basic Earnings Per Share | ||
Diluted Earnings Per Share | $144.1K | |
COMMON SHARES | ||
Basic Shares Outstanding | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 Q2 | 2020 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $100.0K | |
YoY Change | ||
Cash & Equivalents | $34.57M | $1.737M |
Short-Term Investments | ||
Other Short-Term Assets | $180.0K | |
YoY Change | ||
Inventory | ||
Prepaid Expenses | $176.7K | |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $279.1K | |
YoY Change | ||
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $517.5M | |
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $517.5M | |
YoY Change | ||
TOTAL ASSETS | ||
Total Short-Term Assets | $279.1K | |
Total Long-Term Assets | $517.5M | |
Total Assets | $517.8M | |
YoY Change | ||
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | $1.800M | |
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | ||
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $1.805M | |
YoY Change | ||
LONG-TERM LIABILITIES | ||
Long-Term Debt | ||
YoY Change | ||
Other Long-Term Liabilities | $61.94M | |
YoY Change | ||
Total Long-Term Liabilities | $61.94M | |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $1.805M | |
Total Long-Term Liabilities | $61.94M | |
Total Liabilities | $63.75M | |
YoY Change | ||
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$63.47M | -$59.91M |
YoY Change | 5.95% | |
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$63.47M | -$59.91M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $517.8M | |
YoY Change |
Cashflow Statement
Concept | 2021 Q2 | 2020 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $11.77M | -$8.484M |
YoY Change | -238.76% | |
Depreciation, Depletion And Amortization | $89.00K | |
YoY Change | ||
Cash From Operating Activities | $17.19M | |
YoY Change | ||
INVESTING ACTIVITIES | ||
Capital Expenditures | -$1.793M | |
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $0.00 | |
YoY Change | ||
Cash From Investing Activities | -$1.793M | |
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -12.29M | |
YoY Change | ||
NET CHANGE | ||
Cash From Operating Activities | 17.19M | |
Cash From Investing Activities | -1.793M | |
Cash From Financing Activities | -12.29M | |
Net Change In Cash | 3.103M | |
YoY Change | ||
FREE CASH FLOW | ||
Cash From Operating Activities | $17.19M | |
Capital Expenditures | -$1.793M | |
Free Cash Flow | $18.98M | |
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-06-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-39331 | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
E9 | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
98-1531250 | ||
CY2020Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
31882 | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
1966155 | ||
us-gaap |
Costs And Expenses
CostsAndExpenses
|
36866 | ||
CY2021Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-248983 | |
CY2020Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-31882 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1966155 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-36866 | ||
CY2020Q2 | treb |
Offering Costs Related To Warrants And Fpa
OfferingCostsRelatedToWarrantsAndFpa
|
1381051 | |
treb |
Offering Costs Related To Warrants And Fpa
OfferingCostsRelatedToWarrantsAndFpa
|
1381051 | ||
CY2021Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
5606333 | |
CY2020Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
4077333 | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-9174001 | ||
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
4077333 | ||
CY2021Q2 | treb |
Fair Value Adjustment Of Fpa
FairValueAdjustmentOfFpa
|
0 | |
CY2020Q2 | treb |
Fair Value Adjustment Of Fpa
FairValueAdjustmentOfFpa
|
2993421 | |
treb |
Fair Value Adjustment Of Fpa
FairValueAdjustmentOfFpa
|
-7494372 | ||
treb |
Fair Value Adjustment Of Fpa
FairValueAdjustmentOfFpa
|
2993421 | ||
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
843643 | |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
102402 | |
CY2020Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1736513 | |
CY2021Q2 | treb |
Gain Loss On Termination Of Fpa
GainLossOnTerminationOfFpa
|
3160168 | |
treb |
Gain Loss On Termination Of Fpa
GainLossOnTerminationOfFpa
|
3160168 | ||
treb |
Initial Classification Of Warrant Liability
InitialClassificationOfWarrantLiability
|
35676668 | ||
treb |
Initial Classification Of Forward Purchase Agreement Liability
InitialClassificationOfForwardPurchaseAgreementLiability
|
255538 | ||
treb |
Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
|
517500000 | ||
treb |
Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
|
5877460 | ||
treb |
Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
|
18112500 | ||
treb |
Stock Issuance Costs Incurred But Not Yet Paid
StockIssuanceCostsIncurredButNotYetPaid
|
534818 | ||
CY2021Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2021Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001805833 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
treb |
Transition Report
TransitionReport
|
true | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
treb |
Redemption Of Shares Calculated Based On Number Of Business Days Prior To Consummation Of Business Combination
RedemptionOfSharesCalculatedBasedOnNumberOfBusinessDaysPriorToConsummationOfBusinessCombination
|
P2D | ||
CY2021Q2 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
CY2020Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | |
CY2021Q2 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | |
CY2021Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
dei |
Entity Registrant Name
EntityRegistrantName
|
Trebia Acquisition Corp. | ||
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
|
0 | ||
CY2021Q2 | us-gaap |
Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
|
0 | |
CY2021Q2 | us-gaap |
Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
|
0 | |
treb |
Threshold Trading Days For Determining Threshold Post Closing Dollar Volume Weighted Average Price
ThresholdTradingDaysForDeterminingThresholdPostClosingDollarVolumeWeightedAveragePrice
|
P20D | ||
treb |
Threshold Consecutive Trading Days For Determining Threshold Post Closing Dollar Volume Weighted Average Price
ThresholdConsecutiveTradingDaysForDeterminingThresholdPostClosingDollarVolumeWeightedAveragePrice
|
P30D | ||
treb |
Threshold Trading Days For Transfer Assign Or Sale Of Shares Or Warrants After Completion Of Initial Business Combination
ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination
|
P20D | ||
treb |
Threshold Consecutive Trading Days For Transfer Assign Or Sale Of Shares Or Warrants After Completion Of Initial Business Combination
ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination
|
P30D | ||
CY2021Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
150000 | ||
CY2020Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
209790 | |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
243771 | ||
CY2021Q2 | us-gaap |
Assets Current
AssetsCurrent
|
279069 | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
519281229 | ||
CY2021Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
176667 | |
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
41 Madison Avenue, Suite 2020 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10010 | ||
dei |
City Area Code
CityAreaCode
|
646 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
450-9187 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
true | ||
CY2021Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
102402 | |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
843643 | |
CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1053433 | |
CY2021Q2 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
517500000 | |
CY2020Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
517500000 | |
CY2021Q2 | us-gaap |
Assets
Assets
|
517779069 | |
CY2020Q4 | us-gaap |
Assets
Assets
|
518553433 | |
CY2021Q2 | treb |
Accrued Liabilities Excluding Offering Costs Current
AccruedLiabilitiesExcludingOfferingCostsCurrent
|
1804841 | |
CY2020Q4 | treb |
Accrued Liabilities Excluding Offering Costs Current
AccruedLiabilitiesExcludingOfferingCostsCurrent
|
613050 | |
CY2021Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1804841 | |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
613050 | |
CY2021Q2 | us-gaap |
Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
|
43831334 | |
CY2020Q4 | us-gaap |
Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
|
53005335 | |
CY2020Q4 | treb |
Fpa Liability
FpaLiability
|
10654540 | |
CY2021Q2 | treb |
Deferred Underwriting Compensation Noncurrent
DeferredUnderwritingCompensationNoncurrent
|
18112500 | |
CY2020Q4 | treb |
Deferred Underwriting Compensation Noncurrent
DeferredUnderwritingCompensationNoncurrent
|
18112500 | |
CY2021Q2 | us-gaap |
Liabilities
Liabilities
|
63748675 | |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
82385425 | |
CY2021Q2 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
517500000 | |
CY2020Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
511622540 | |
CY2021Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2021Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
847038 | |
CY2020Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
6724439 | |
CY2021Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-64317938 | |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-82180324 | |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-63469606 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-75454532 | |
CY2021Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
517779069 | |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
518553433 | |
CY2021Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
248983 | |
CY2021Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-2446165 | |
CY2020Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-8451805 | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
19828541 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-8451805 | ||
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2695148 | |
CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8483687 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
17862386 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-8488671 | ||
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-75454532 | |
CY2021Q1 | treb |
Changeinvalueofordinarysharessubjecttopossibleredemptionvalue
Changeinvalueofordinarysharessubjecttopossibleredemptionvalue
|
5877460 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
20557534 | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-60774458 | |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2695148 | |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-63469606 | |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | |
CY2020Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
25000 | |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4984 | |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
20016 | |
CY2020Q2 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
823332 | |
CY2020Q2 | treb |
Offering Costs Allocated To Equity In Connection With Ipo
OfferingCostsAllocatedToEquityInConnectionWithIpo
|
27860038 | |
CY2020Q2 | treb |
Initial Classification Of Public Warrants
InitialClassificationOfPublicWarrants
|
24150000 | |
CY2020Q2 | treb |
Initial Classification Of Fpa Liability
InitialClassificationOfFpaLiability
|
255538 | |
CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8483687 | |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-59905915 | |
us-gaap |
Profit Loss
ProfitLoss
|
17862386 | ||
us-gaap |
Profit Loss
ProfitLoss
|
-8488671 | ||
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-9174001 | ||
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
4077333 | ||
treb |
Fair Value Adjustment Of Fpa
FairValueAdjustmentOfFpa
|
-7494372 | ||
treb |
Fair Value Adjustment Of Fpa
FairValueAdjustmentOfFpa
|
2993421 | ||
treb |
Gain Loss On Termination Of Fpa
GainLossOnTerminationOfFpa
|
3160168 | ||
treb |
Transaction Costs Incurred In Connection With Ipo
TransactionCostsIncurredInConnectionWithIpo
|
1381051 | ||
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-33123 | ||
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
24517 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1191791 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
16667 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-741241 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-44716 | ||
treb |
Investmentofcashintrustaccount
Investmentofcashintrustaccount
|
517500000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-517500000 | ||
treb |
Proceeds From Sale Of Units Net Of Underwriting Discounts Paid
ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid
|
507150000 | ||
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
12350000 | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
25000 | ||
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
150000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-741241 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1736513 | ||
treb |
Threshold Period For Not To Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination
ThresholdPeriodForNotToTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination
|
P180D | ||
CY2021Q2 | treb |
Cash Held Outside Trust Account
CashHeldOutsideTrustAccount
|
102402 | |
CY2020Q4 | treb |
Cash Held Outside Trust Account
CashHeldOutsideTrustAccount
|
843643 | |
CY2020Q2 | treb |
Investment Of Cash In Trust Account
InvestmentOfCashInTrustAccount
|
517500000 | |
treb |
Threshold Minimum Aggregate Fair Market Value As Percentage Of Assets Held In Trust Account
ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount
|
0.80 | ||
treb |
Threshold Percentage Of Outstanding Voting Securities Of Target To Be Acquired By Post Transaction Company To Complete Business Combination
ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination
|
0.50 | ||
CY2021Q2 | treb |
Minimum Net Tangible Assets Upon Consummation Of Business Combination
MinimumNetTangibleAssetsUponConsummationOfBusinessCombination
|
5000001 | |
treb |
Threshold Percentage Of Public Shares Subject To Redemption Without Companys Prior Written Consent
ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanysPriorWrittenConsent
|
0.15 | ||
treb |
Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
|
1 | ||
treb |
Threshold Business Days For Redemption Of Public Shares
ThresholdBusinessDaysForRedemptionOfPublicShares
|
P10D | ||
treb |
Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
|
1 | ||
treb |
Maximum Net Interest To Pay Dissolution Expenses
MaximumNetInterestToPayDissolutionExpenses
|
100000 | ||
CY2021Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
102402 | |
CY2021Q2 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
517500000 | |
CY2021Q2 | treb |
Working Capital Deficit
WorkingCapitalDeficit
|
1525772 | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p> | ||
treb |
Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Stock Price Trigger
TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger
|
12.00 | ||
treb |
Threshold Period After Business Combination In Which Specified Trading Days Within Any Specified Trading Day Period Commences
ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences
|
P150D | ||
CY2021Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
51750000 | |
CY2020Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
51750000 | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
51750000 | ||
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
51457751 | ||
CY2021Q2 | treb |
Deferred Underwriting Compensation Noncurrent
DeferredUnderwritingCompensationNoncurrent
|
18112500 | |
us-gaap |
Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
|
2865567 | ||
CY2020 | us-gaap |
Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
|
2853572 | |
treb |
Threshold Post Closing Dollar Volume Weighted Average Price
ThresholdPostClosingDollarVolumeWeightedAveragePrice
|
12.50 | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p> | ||
CY2020Q2 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
29241089 | |
CY2020Q2 | treb |
Deferred Offering Costs Current
DeferredOfferingCostsCurrent
|
28462500 | |
CY2020Q2 | treb |
Sale Of Stock Other Offering Costs
SaleOfStockOtherOfferingCosts
|
778589 | |
CY2020Q2 | treb |
Offering Cost Expenses
OfferingCostExpenses
|
1381051 | |
treb |
Amount Of Shareholder Redemption Need To Exceed For Dollar To Dollar Adjustment Of Consideration
AmountOfShareholderRedemptionNeedToExceedForDollarToDollarAdjustmentOfConsideration
|
417500000 | ||
CY2021Q2 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | ||
CY2021Q2 | treb |
Maximum Number Of Demands For Registration Of Securities
MaximumNumberOfDemandsForRegistrationOfSecurities
|
3 | |
treb |
Period After Closing Of Initial Business Combination To File Resale Shelf Registration Statement
PeriodAfterClosingOfInitialBusinessCombinationToFileResaleShelfRegistrationStatement
|
P30D | ||
CY2021Q2 | treb |
Deferred Fee Per Unit
DeferredFeePerUnit
|
0.35 | |
CY2021Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
8233334 | |
CY2021Q2 | treb |
Class Of Warrant Or Right Price Of Warrants Or Rights
ClassOfWarrantOrRightPriceOfWarrantsOrRights
|
1.50 | |
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
12350000 | ||
CY2021Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
|
1 | |
CY2021Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
11.50 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2021Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2021Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
treb |
Class Of Warrant Or Right Redemption Of Warrants Or Rights Stock Price Trigger
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
|
18.00 | ||
CY2021Q2 | us-gaap |
Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
|
43831334 | |
CY2020Q4 | us-gaap |
Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
|
53005335 | |
CY2020Q4 | treb |
Fpa Liability
FpaLiability
|
10654540 | |
CY2020Q4 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
63659875 | |
CY2021Q2 | treb |
Fpa Liability
FpaLiability
|
0 | |
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
|
0 |